Australian & New Zealand Childrens Haematology/Oncology Group

Clinical Trials

Viewing: Clinical Trials

Filter by

Progressive high-risk solid tumours or central nervous system tumours

Status: Open | NSW , VIC , WA

INFORM2 NivEnt: Phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies

Solid tumour: High risk neuroblastoma

Status: In Development

HR-NBM study: High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Peripheral neuroblastic tumours

Status: Open | NSW , QLD , TAS , VIC , WA , SA

SIOPEN SCI Registry: Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting with Spinal Canal Involvement

Neuroblastoma

Status: Open | NSW , VIC , WA

LINES: European Low and Intermediate Risk Neuroblastoma (Phase III SIOPEN study)

Brain tumours

Status: Closed to Recruitment | NSW , QLD , TAS , VIC , WA , SA , New Zealand

MNP2.0: Molecular Neuropathology 2.0

NF-1 associated plexiform neurofibromas or progressive optic pathway gliomas

Status: Open | NSW , QLD , TAS , VIC , WA , SA , New Zealand

TINT: A phase II study of trametinib in paediatric, adolescent and young adult patients with Neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas.

All posts loaded.

All posts loaded.

Load more trials